Instituto Rosenbusch S.A. (ROSE) - Net Assets

Latest as of December 2025: AR$-526.19 Million ARS ≈ $-380.75K USD

Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) has net assets worth AR$-526.19 Million ARS (≈ $-380.75K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AR$7.75 Billion ≈ $5.60 Million USD) and total liabilities (AR$8.27 Billion ≈ $5.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore total assets of Instituto Rosenbusch S.A. for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AR$-526.19 Million
% of Total Assets	-6.79%
Annual Growth Rate	N/A
5-Year Change	-364.17%
10-Year Change	-732.17%
Growth Volatility	203.92

Instituto Rosenbusch S.A. - Net Assets Trend (2000–2025)

This chart illustrates how Instituto Rosenbusch S.A.'s net assets have evolved over time, based on quarterly financial data. Check ROSE tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Instituto Rosenbusch S.A. (2000–2025)

The table below shows the annual net assets of Instituto Rosenbusch S.A. from 2000 to 2025. For live valuation and market cap data, see market value of Instituto Rosenbusch S.A..

Year	Net Assets	Change
2025-12-31	AR$-526.19 Million ≈ $-380.75K	-113.19%
2024-12-31	AR$3.99 Billion ≈ $2.89 Million	-12.26%
2023-12-31	AR$4.55 Billion ≈ $3.29 Million	+1035.45%
2022-12-31	AR$400.51 Million ≈ $289.81K	+101.07%
2021-12-31	AR$199.19 Million ≈ $144.13K	+34.87%
2020-12-31	AR$147.69 Million ≈ $106.87K	+27.86%
2019-12-31	AR$115.52 Million ≈ $83.59K	-20.85%
2018-12-31	AR$145.95 Million ≈ $105.61K	+68.58%
2017-12-31	AR$86.58 Million ≈ $62.65K	+4.01%
2016-12-31	AR$83.24 Million ≈ $60.23K	+17.86%
2015-12-31	AR$70.62 Million ≈ $51.10K	+3.48%
2014-12-31	AR$68.24 Million ≈ $49.38K	+18.37%
2013-12-31	AR$57.65 Million ≈ $41.72K	-12.49%
2012-12-31	AR$65.88 Million ≈ $47.67K	+17.13%
2011-12-31	AR$56.25 Million ≈ $40.70K	+12.05%
2010-12-31	AR$50.20 Million ≈ $36.32K	+6.93%
2009-12-31	AR$46.95 Million ≈ $33.97K	+2.85%
2008-12-31	AR$45.65 Million ≈ $33.03K	+21.73%
2007-12-31	AR$37.50 Million ≈ $27.13K	+4.25%
2006-12-31	AR$35.97 Million ≈ $26.03K	+5.37%
2005-12-31	AR$34.13 Million ≈ $24.70K	+12.26%
2004-12-31	AR$30.41 Million ≈ $22.00K	+7.58%
2003-12-31	AR$28.27 Million ≈ $20.45K	+16.96%
2002-12-31	AR$24.17 Million ≈ $17.49K	+91.96%
2001-12-31	AR$12.59 Million ≈ $9.11K	+5.80%
2000-12-31	AR$11.90 Million ≈ $8.61K	--

Equity Component Analysis

This analysis shows how different components contribute to Instituto Rosenbusch S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 297534.7% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	AR$8.09 Billion	%
Total Equity	AR$-800.17 Million	100.00%

Instituto Rosenbusch S.A. Competitors by Market Cap

The table below lists competitors of Instituto Rosenbusch S.A. ranked by their market capitalization.

Company	Market Cap
Samchai Steel Industries Public Company Limited BK:SAM	$4.89 Million
Conferize A/S CO:CONFRZ	$4.89 Million
Hapbee Technologies Inc V:HAPB	$4.90 Million
Ravi Kumar Distilleries Limited NSE:RKDL	$4.91 Million
Tianci International, Inc. Common Stock NASDAQ:CIIT	$4.88 Million
Metals Exploration Plc LSE:MTL	$4.88 Million
Fluicell AB ST:FLUI	$4.88 Million
Optima Prima Metal Sinergi JK:OPMS	$4.88 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Instituto Rosenbusch S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 3,739,171,982 to -800,168,048, a change of -4,539,340,030 (-121.4%).
Net loss of 4,597,736,040 reduced equity.
Other factors increased equity by 58,396,010.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AR$-4.60 Billion	-574.6%
Other Changes	AR$58.40 Million	+7.3%
Total Change	AR$-	-121.40%

Book Value vs Market Value Analysis

This analysis compares Instituto Rosenbusch S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	AR$1.81	AR$158.50	x
2018-12-31	AR$3.00	AR$158.50	x
2019-12-31	AR$2.46	AR$158.50	x
2020-12-31	AR$3.06	AR$158.50	x
2021-12-31	AR$4.16	AR$158.50	x
2022-12-31	AR$8.52	AR$158.50	x
2023-12-31	AR$97.89	AR$158.50	x
2024-12-31	AR$87.80	AR$158.50	x
2025-12-31	AR$-18.79	AR$158.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Instituto Rosenbusch S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -71.80%
• Asset Turnover: 0.83x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-0.45%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2000	8.43%	12.27%	0.56x	1.24x	AR$-186.90K
2001	4.87%	6.96%	0.57x	1.22x	AR$-645.90K
2003	12.52%	11.66%	0.85x	1.26x	AR$713.50K
2004	8.30%	5.79%	1.11x	1.29x	AR$-516.80K
2005	12.18%	7.66%	1.19x	1.33x	AR$743.50K
2006	11.40%	6.12%	1.38x	1.35x	AR$503.20K
2007	4.80%	2.36%	1.40x	1.45x	AR$-1.93 Million
2009	2.13%	1.67%	0.91x	1.40x	AR$-3.62 Million
2010	6.02%	5.19%	0.77x	1.50x	AR$-1.95 Million
2011	10.56%	8.00%	0.83x	1.60x	AR$306.90K
2012	14.54%	11.20%	0.72x	1.80x	AR$2.90 Million
2014	13.04%	7.75%	0.76x	2.20x	AR$1.94 Million
2015	-1.13%	-0.54%	0.82x	2.57x	AR$-7.19 Million
2016	13.42%	6.07%	0.85x	2.61x	AR$2.59 Million
2017	-0.09%	-0.04%	0.81x	2.77x	AR$-7.78 Million
2018	0.62%	0.27%	0.82x	2.87x	AR$-11.97 Million
2019	-85.11%	-21.66%	0.83x	4.74x	AR$-99.69 Million
2020	-13.07%	-3.04%	0.83x	5.19x	AR$-30.02 Million
2021	-11.06%	-2.50%	1.05x	4.22x	AR$-37.27 Million
2022	-2.23%	-0.59%	1.02x	3.72x	AR$-44.38 Million
2023	29.40%	12.43%	0.90x	2.63x	AR$808.98 Million
2024	-49.86%	-17.13%	1.10x	2.65x	AR$-2.24 Billion
2025	0.00%	-71.80%	0.83x	0.00x	AR$-4.52 Billion

Industry Comparison

This section compares Instituto Rosenbusch S.A.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $3,380,505,644
Average return on equity (ROE) among peers: 14.38%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Instituto Rosenbusch S.A. (ROSE)	AR$-526.19 Million	8.43%	N/A	$4.88 Million
Laboratorios Richmond SACIF (RICH)	$3.38 Billion	14.38%	1.41x	$75.88 Million

About Instituto Rosenbusch S.A.

BA:ROSE Argentina Drug Manufacturers - Specialty & Generic

Market Cap

$4.88 Million

AR$6.75 Billion ARS

Market Cap Rank

#28653 Global

#77 in Argentina

Share Price

AR$158.50

Change (1 day)

+0.96%

52-Week Range

AR$119.50 - AR$327.00

All Time High

AR$380.00